Medium-chain Triglyceride Ketogenic Diet, An Effective Treatment for Drug-resistant Epilepsy and A Comparison with Other Ketogenic Diets

  title={Medium-chain Triglyceride Ketogenic Diet, An Effective Treatment for Drug-resistant Epilepsy and A Comparison with Other Ketogenic Diets},
  author={Yeou-mei Christiana Liu and Huei-Shyong Wang},
  journal={Biomedical Journal},
  pages={9 - 15}
The ketogenic diet (KD) is one of the most effective therapies for drug-resistant epilepsy. The efficacy of the medium-chain triglyceride KD (MCTKD) is as excellent as the classic KD (CKD), which has been documented in several subsequent retrospective, prospective, and randomized studies. MCT oil is more ketogenic than long-chain triglycerides. Therefore, the MCTKD allows more carbohydrate and protein food, which makes the diet more palatable than the CKD. The MCTKD is not based on diet ratios… 

Tables from this paper

The place of a ketogenic diet in the treatment of resistant epilepsy: a comprehensive review.

It is argued that KD is one of the most effective treatments for epilepsy and the fact that KDs generally have a restricted diet pattern, the need for supplementation, biochemical findings and possible side effects raise the issue of diet sustainability.

Updates on the ketogenic diet therapy for pediatric epilepsy

Ketogenic Diet Therapy for Epilepsy Management

  • F. Wei
  • Medicine
    Biomedical journal
  • 2013
This special edition includes three review articles on current advances in ketogenic diet therapy for epilepsy management and the classic name, ketogenic Diet therapy, may more appropriately be replaced by the name metabolic diet therapy.

Ketogenic diet: overview, types, and possible anti-seizure mechanisms

The aim of the present study was to review the various types of KD and explain the probable biochemical mechanisms involved in its anti-seizure property.

Ketogenic Nutrition and Health

The ketogenic diet (KD) is a high-fat, adequate-protein and very low-carb diet regimen that simulates/mimics the metabolism of the fasting state to stimulate the production of ketone bodies. KD has

Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations

It is suggested that, with encouraging evidence of therapeutic effects and increasing insights into the mechanisms of action, randomized controlled trials should be conducted to elucidate a foundation for the clinical use of the ketogenic diet.

Ketogenic diets: Opportunities and limitations in practical application (LITERATURE REVIEW)

The literature review provides evidence for KD efficiency in reduction of epileptic seizures in children and adults, but the majority of research and the professional communities of dietologists warn of adverse health effects of KD when used for other conditions.

Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)

  • N. Lyukshina
  • Medicine, Biology
    Russian Journal of Child Neurology
  • 2021
De Vivo disease is characterized by early epileptic encephalopathy, delayed psychomotor development, spasticity, the formation of microcephaly, ataxia, dysarthria, alternating hemiplegia, and a



Medium‐chain triglycerides as a therapy for intractable childhood epilepsy

A diet containing sufficient MCT to induce ketonuria was devised and its effects have been tested in a group of children and adolescents with intractable seizures.

Medium‐chain triglyceride (MCT) ketogenic therapy

The medium‐chain triglyceride diet should remain a viable dietary option for children with refractory epilepsy who have large appetites, can tolerate more calories, or cannot accept the restrictions of the classic KD.


The three ketogenic diets were shown to be effective in the short‐term management of children whose epilepsy is poorly controlled with anticonvulsant drugs.

The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial

Prospective Study of the Modified Atkins Diet in Combination With a Ketogenic Liquid Supplement During the Initial Month

The addition of a ketogenic supplement to the modified Atkins diet during its initial month appears to be beneficial and increased daily fat intake and thus the ketogenic ratio, but did not change urinary or serum ketosis.

Low glycemic index treatment: Implementation and new insights into efficacy

The LGIT approach produces comparable efficacy to the classic KD, but tolerability is improved and implementation is much simpler, and appears to be a viable first‐line dietary therapy for epilepsy.

Discontinuing the Ketogenic Diet in Seizure‐Free Children: Recurrence and Risk Factors

The presence of recent EEG epileptiform activity, abnormal MRI, lower initial seizure frequency, and tuberous sclerosis complex all significantly increased the likelihood of recurrence of seizures in children started on the ketogenic diet.

A prospective study: growth and nutritional status of children treated with the ketogenic diet.

When treating children on a ketogenic diet, clinicians should recommend adequate intake of energy and protein, a higher proportion of unsaturated to saturated dietary fats, and consider vitamin and mineral supplements.